Together Pharma Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	67	54	34	19	68	136	Upgrade
Market Cap Growth	58.74%	58.74%	82.58%	-72.51%	-50.07%	-23.85%	Upgrade
Enterprise Value	127	112	92	61	138	177	Upgrade
Last Close Price	3.89	3.92	3.88	2.48	10.62	24.31	Upgrade
PE Ratio	-	-	-	-	-	19.02	Upgrade
PS Ratio	0.70	0.56	0.38	0.60	5.65	12.12	Upgrade
PB Ratio	1.76	1.42	-13.36	6.18	2.64	9.24	Upgrade
P/TBV Ratio	7.83	6.29	-	-	-	-	Upgrade
P/FCF Ratio	49.07	39.38	2.44	-	-	-	Upgrade
P/OCF Ratio	23.67	18.99	2.30	-	-	-	Upgrade
EV/Sales Ratio	1.33	1.16	1.01	1.97	11.50	15.80	Upgrade
EV/EBITDA Ratio	12.61	12.52	3.33	-	-	8.63	Upgrade
EV/EBIT Ratio	38.95	34.17	4.16	-	-	10.66	Upgrade
EV/FCF Ratio	92.75	81.38	6.58	-	-	-	Upgrade
Debt / Equity Ratio	1.66	1.66	-21.48	19.88	3.32	3.89	Upgrade
Debt / EBITDA Ratio	6.29	6.29	1.92	-	-	2.74	Upgrade
Debt / FCF Ratio	46.26	46.26	3.92	-	-	-	Upgrade
Asset Turnover	0.67	0.67	0.68	0.22	0.09	0.12	Upgrade
Inventory Turnover	1.41	1.41	1.13	0.82	0.34	-	Upgrade
Quick Ratio	0.36	0.36	0.27	0.29	0.09	0.37	Upgrade
Current Ratio	1.07	1.07	1.17	1.25	1.32	2.12	Upgrade
Return on Equity (ROE)	-9.09%	-9.09%	-1076.01%	-246.99%	-74.80%	1175.31%	Upgrade
Return on Assets (ROA)	1.43%	1.43%	10.29%	-8.57%	-5.04%	10.77%	Upgrade
Return on Capital (ROIC)	2.66%	2.66%	23.94%	-14.19%	-7.82%	26.06%	Upgrade
Return on Capital Employed (ROCE)	4.80%	4.80%	28.90%	-	-	16.00%	Upgrade
Earnings Yield	-1.74%	-2.17%	-12.66%	-179.57%	-20.28%	5.26%	Upgrade
FCF Yield	2.04%	2.54%	40.97%	-75.34%	-29.70%	-17.24%	Upgrade
Buyback Yield / Dilution	-41.39%	-41.39%	-7.81%	-18.96%	-18.76%	-14.93%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.